Published

Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychiatry research
Date: 2026-05-01
Source: PubMed
DOI: 10.1016/j.psychres.2026.117010
PubMed: 41747432

Authors

Goldy SP Sepeda ND Hilbert SN Bari BA Garcia-Romeu A Gukasyan N Barrett FS Yaden DB Nayak SM

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Clinical Trial Healthy Volunteers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2024-01-01 Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27 Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disordersPsychedelics. · 2025-06-10 The development of psilocybin therapy for treatment-resistant depression: an update.BJPsych bulletin · 2024-02-01 Pharmacokinetics of Psilocybin in Normal Adult VolunteersClinicalTrials.gov · 2020-04-15 Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01 Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26 Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexiaPsychedelics. · 2026-02-03